Suppr超能文献

因控制腹水而住院的乙型肝炎病毒相关性肝硬化患者的自然病史。

Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.

作者信息

Kim Seung Up, Han Kwang-Hyub, Nam Chung Mo, Park Jun Yong, Kim Do Young, Chon Chae Yoon, Ahn Sang Hoon

机构信息

Department of Internal Medicine, Yonsei University, College of Medicine, Seoul, South Korea.

出版信息

J Gastroenterol Hepatol. 2008 Nov;23(11):1722-7. doi: 10.1111/j.1440-1746.2008.05510.x. Epub 2008 Aug 20.

Abstract

BACKGROUND AND AIM

Few studies have assessed the natural history of hepatitis B virus (HBV)-related cirrhotic ascites. We investigated the natural history of patients with HBV-related cirrhotic ascites hospitalized to control ascites and determined their prognosis, including survival rates and prognostic factors affecting survival.

METHODS

Between January 1996 and December 2005, 203 consecutive patients with HBV-related cirrhotic ascites were followed for a median of 80.7 months (range, 15-149) after their first significant ascitic decompensation that required hospitalization.

RESULTS

The mean age of all patients was 52.6 years. Male gender predominated (male/female, 138/65). A subgroup analysis of 165 patients who had ascitic decompensation as their first episode of hepatic decompensation revealed that gastrointestinal variceal bleeding developed after a median interval of 8 months following ascitic decompensation in 31 (18.8%) patients, hepatic encephalopathy occurred at 9 months in 53 (32.1%), spontaneous bacterial peritonitis appeared at 12.7 months in 24 (14.5%), hepatorenal syndrome occurred at 8.1 months in five (3%), and hepatocellular carcinoma was observed at 21.2 months in 10 (6.1%). The overall median survival was 12.4 months. The 1- and 3-year survival rates were 50.7 and 18.7%. The prognostic factors that independently correlated with survival at the time of ascitic decompensation were Child-Pugh classification B/C (P = 0.030), serum white blood cell (WBC; P = 0.035), serum creatinine (Cr; P = 0.039), serum sodium (Na; P = 0.010), and antiviral therapy (P = 0.040).

CONCLUSIONS

The prognosis of HBV-related cirrhotic patients with ascitic decompensation is poor. Child-Pugh class, serum WBC/Cr/Na, and antiviral therapy primarily influenced survival.

摘要

背景与目的

很少有研究评估乙型肝炎病毒(HBV)相关肝硬化腹水的自然病史。我们调查了因腹水住院治疗的HBV相关肝硬化腹水患者的自然病史,并确定了他们的预后情况,包括生存率以及影响生存的预后因素。

方法

在1996年1月至2005年12月期间,对203例连续性HBV相关肝硬化腹水患者进行随访,这些患者在首次因严重腹水失代偿而需住院治疗后,随访时间中位数为80.7个月(范围15 - 149个月)。

结果

所有患者的平均年龄为52.6岁。男性占主导(男/女,138/65)。对165例以腹水失代偿作为首次肝脏失代偿发作的患者进行亚组分析发现,31例(18.8%)患者在腹水失代偿后中位间隔8个月出现胃肠道静脉曲张出血,53例(32.1%)在9个月时发生肝性脑病,24例(14.5%)在12.7个月时出现自发性细菌性腹膜炎,5例(3%)在8.1个月时发生肝肾综合征,10例(6.1%)在21.2个月时观察到肝细胞癌。总体生存中位数为12.4个月。1年和3年生存率分别为50.7%和18.7%。在腹水失代偿时与生存独立相关的预后因素为Child-Pugh分级B/C(P = 0.030)、血清白细胞(WBC;P = 0.035)、血清肌酐(Cr;P = 0.039)、血清钠(Na;P = 0.010)以及抗病毒治疗(P = 0.040)。

结论

HBV相关肝硬化腹水失代偿患者的预后较差。Child-Pugh分级、血清WBC/Cr/Na以及抗病毒治疗对生存有主要影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验